The present study shows that MAOB inhibition reduces NF-κB activity in lung cancer cells, whereas in neuronal cells treatment of MAOB inhibitors such as phenelzine and selegiline has been reported to upregulate or not affect NF-κB signals, respectively37, 38. This evidence concerns the gene NFKB1 and lung cancer.